קלרידקס

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

CLARITHROMYCIN

から入手可能:

DEXCEL LTD, ISRAEL

ATCコード:

J01FA09

医薬品形態:

קפליות

構図:

CLARITHROMYCIN 250 MG

投与経路:

פומי

処方タイプ:

מרשם נדרש

製:

DEXCEL LTD, ISRAEL

治療群:

CLARITHROMYCIN

治療領域:

CLARITHROMYCIN

適応症:

Klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. Indications include: Lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. Upper respiratory tract infections, for example, sinusitis and pharyngitis. Klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. Klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. Klaridex is also indicated in combination with proton pump inhibitor for the eradication of H. Pylori in patients with proven duodenal ulcer. Treatment of Mycobacterium Avium Complex infection in AIDS patients.

承認日:

2014-05-31